MAGE-3 peptide

MAGE-3 peptide

• CAS Number: 154652-68-3
• UNSPSC Description: MAGE-3 peptide (MAGE-3 168-176, human) is a peptide encoded by human MAGE-3 gene, which is expressed in tumor cells, presented by HLA and recognized by cytolytic T lymphocytes (CTL) as tumor antigen[1].
• Target Antigen: Others
• Type: Peptides
• Related Pathways: Others
• Applications: Cancer-programmed cell death
• Field of Research: Cancer
• Assay Protocol: https://www.medchemexpress.com/mage-3-peptide.html
• Solubility: 10 mM in DMSO
• Smiles: OC(CC[C@H](N)C(N[C@@H](C(C)C)C(N[C@@H](CC(O)=O)C(N1[C@@H](CCC1)C(N[C@@H]([C@@H](C)CC)C(NCC(N[C@H](C(N[C@@H](CC(C)C)C(N[C@H](C(O)=O)CC2=CC=C(C=C2)O)=O)=O)CC3=CN=CN3)=O)=O)=O)=O)=O)=O)=O
• Molecular Weight: 1042.14
• References & Citations: [1]Schultz ES, et al., A MAGE-3 peptide recognized on HLA-B35 and HLA-A1 by cytolytic T lymphocytes. Tissue Antigens. 2001 Feb;57(2):103-9.
• Shipping Conditions: Room temperature
• Clinical Information: No Development Reported